Surgery, Vascular and Endovascular Surgery

Organization

School of Medicine > Clinical Science Departments > Surgery > Surgery, Vascular and Endovascular Surgery

Overview

People

Embed Organization Data

Embed Organization Data

Recent Scholarship

scholar cap and tassel

book

Featured Publications

Explantation of fenestrated endograft complicated by complete junctional dissociation and symptomatic type IIIa endoleak.

Journal Article J Vasc Surg Cases Innov Tech · February 2026 Full text Link to item Cite

Social Vulnerability as a Neighborhood-Level Determinant of Pancreatic Cancer Survivorship: A National Analysis of Veterans Affairs Patients.

Conference Ann Surg Oncol · February 2026 Full text Link to item Cite

A multimethod assessment of the vascular surgery program director experience in creating effective training environments.

Journal Article J Vasc Surg · January 2026 Full text Link to item Cite

Search More

Featured Grants

Prospective, non-randomized staged pivotal clinical study to assess the safety and performance of the Xeltis Hemodialysis Access graft: Xeltis aXess US Pivotal

Clinical Trial · Awarded by Xeltis, Inc. · 2025 - 2036

Assessment of Long Term, Endovascular AAA Intervention using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis

Clinical Trial · Awarded by W. L. Gore & Associates, Inc. · 2024 - 2034

Randomized Controlled Clinical Trial (RCT) of the Nectero EAST System for Small to Mid-Sized Abdominal Aortic Aneurysms (AAA) StaBiLization: Evaluation of Efficacy.

Clinical Trial · Awarded by Nectero Medical, Inc. · 2024 - 2034

A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients with End-Stage Renal Disease

Clinical Trial · Awarded by W. L. Gore & Associates, Inc. · 2024 - 2032

A Phase 3 Randomized Study to Compare the Efficacy and Safety of the Humacyte Human Acellular Vessel (HAV) with that of an Autogenous Arteriovenous Fistula (AVF) in Female Patients with End-Stage Renal Disease Requiring He- CLN-Pro-V012 - Pro00114567

Clinical Trial · Awarded by Humacyte Global, Inc. · 2024 - 2032

Search More